Selected research
Industry Research
Safety Lancets Industry Research Report 2026
Market perspective
The global Safety Lancets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Safety Lancets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Safety Lancets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Safety Lancets include Tianjin Huahong, SteriLance Medical, Shandong Lianfa, Roche, Guangzhou iCare Medical, B. Braun, UltiMed, Terumo and Sarstedt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Safety Lancets market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Safety Lancets Market by Company
Tianjin Huahong
SteriLance Medical
Shandong Lianfa
Roche
Guangzhou iCare Medical
B. Braun
UltiMed
Terumo
Sarstedt
Owen Mumford
Nipro
Lifescan
ICU Medical
HTL-STREFA
HemoCue
Greiner Bio One
Cardinal Health
BD
Ascensia
ARKRAY
Safety Lancets Segment by Type
Safety Lancets with Needle
Safety Lancets with Blade
Safety Lancets Segment by Application
Hospital & Clinics
Home
Other
Safety Lancets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Safety Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Safety Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Safety Lancets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Safety Lancets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Safety Lancets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Safety Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Safety Lancets with Needle
- Safety Lancets with Blade
Applications
- Hospital & Clinics
- Home
- Other
Companies covered
- Tianjin Huahong
- SteriLance Medical
- Shandong Lianfa
- Roche
- Guangzhou iCare Medical
- B. Braun
- UltiMed
- Terumo
- Sarstedt
- Owen Mumford
- Nipro
- Lifescan
- ICU Medical
- HTL-STREFA
- HemoCue
- Greiner Bio One
- Cardinal Health
- BD
- Ascensia
- ARKRAY
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Safety Lancets Market Size (2021-2032)
- 2.2.2 Global Safety Lancets Sales (2021-2032)
- 2.2.3 Global Safety Lancets Market Average Price (2021-2032)
- 2.3 Safety Lancets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Safety Lancets with Needle
- 2.3.3 Safety Lancets with Blade
- 2.4 Safety Lancets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital & Clinics
- 2.4.3 Home
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Safety Lancets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Safety Lancets Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Safety Lancets Revenue of Manufacturers (2021-2026)
- 3.4 Global Safety Lancets Average Price by Manufacturers (2021-2026)
- 3.5 Global Safety Lancets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Safety Lancets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Safety Lancets, Product Type & Application
- 3.8 Global Manufacturers of Safety Lancets, Established Date
- 3.9 Global Safety Lancets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Tianjin Huahong
- 4.1.1 Tianjin Huahong Company Information
- 4.1.2 Tianjin Huahong Business Overview
- 4.1.3 Tianjin Huahong Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Tianjin Huahong Safety Lancets Product Portfolio
- 4.1.5 Tianjin Huahong Recent Developments
- 4.2 SteriLance Medical
- 4.2.1 SteriLance Medical Company Information
- 4.2.2 SteriLance Medical Business Overview
- 4.2.3 SteriLance Medical Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 SteriLance Medical Safety Lancets Product Portfolio
- 4.2.5 SteriLance Medical Recent Developments
- 4.3 Shandong Lianfa
- 4.3.1 Shandong Lianfa Company Information
- 4.3.2 Shandong Lianfa Business Overview
- 4.3.3 Shandong Lianfa Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Lianfa Safety Lancets Product Portfolio
- 4.3.5 Shandong Lianfa Recent Developments
- 4.4 Roche
- 4.4.1 Roche Company Information
- 4.4.2 Roche Business Overview
- 4.4.3 Roche Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roche Safety Lancets Product Portfolio
- 4.4.5 Roche Recent Developments
- 4.5 Guangzhou iCare Medical
- 4.5.1 Guangzhou iCare Medical Company Information
- 4.5.2 Guangzhou iCare Medical Business Overview
- 4.5.3 Guangzhou iCare Medical Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Guangzhou iCare Medical Safety Lancets Product Portfolio
- 4.5.5 Guangzhou iCare Medical Recent Developments
- 4.6 B. Braun
- 4.6.1 B. Braun Company Information
- 4.6.2 B. Braun Business Overview
- 4.6.3 B. Braun Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 B. Braun Safety Lancets Product Portfolio
- 4.6.5 B. Braun Recent Developments
- 4.7 UltiMed
- 4.7.1 UltiMed Company Information
- 4.7.2 UltiMed Business Overview
- 4.7.3 UltiMed Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 UltiMed Safety Lancets Product Portfolio
- 4.7.5 UltiMed Recent Developments
- 4.8 Terumo
- 4.8.1 Terumo Company Information
- 4.8.2 Terumo Business Overview
- 4.8.3 Terumo Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Terumo Safety Lancets Product Portfolio
- 4.8.5 Terumo Recent Developments
- 4.9 Sarstedt
- 4.9.1 Sarstedt Company Information
- 4.9.2 Sarstedt Business Overview
- 4.9.3 Sarstedt Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sarstedt Safety Lancets Product Portfolio
- 4.9.5 Sarstedt Recent Developments
- 4.10 Owen Mumford
- 4.10.1 Owen Mumford Company Information
- 4.10.2 Owen Mumford Business Overview
- 4.10.3 Owen Mumford Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Owen Mumford Safety Lancets Product Portfolio
- 4.10.5 Owen Mumford Recent Developments
- 4.11 Nipro
- 4.11.1 Nipro Company Information
- 4.11.2 Nipro Business Overview
- 4.11.3 Nipro Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Nipro Safety Lancets Product Portfolio
- 4.11.5 Nipro Recent Developments
- 4.12 Lifescan
- 4.12.1 Lifescan Company Information
- 4.12.2 Lifescan Business Overview
- 4.12.3 Lifescan Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Lifescan Safety Lancets Product Portfolio
- 4.12.5 Lifescan Recent Developments
- 4.13 ICU Medical
- 4.13.1 ICU Medical Company Information
- 4.13.2 ICU Medical Business Overview
- 4.13.3 ICU Medical Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 ICU Medical Safety Lancets Product Portfolio
- 4.13.5 ICU Medical Recent Developments
- 4.14 HTL-STREFA
- 4.14.1 HTL-STREFA Company Information
- 4.14.2 HTL-STREFA Business Overview
- 4.14.3 HTL-STREFA Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 HTL-STREFA Safety Lancets Product Portfolio
- 4.14.5 HTL-STREFA Recent Developments
- 4.15 HemoCue
- 4.15.1 HemoCue Company Information
- 4.15.2 HemoCue Business Overview
- 4.15.3 HemoCue Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 HemoCue Safety Lancets Product Portfolio
- 4.15.5 HemoCue Recent Developments
- 4.16 Greiner Bio One
- 4.16.1 Greiner Bio One Company Information
- 4.16.2 Greiner Bio One Business Overview
- 4.16.3 Greiner Bio One Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Greiner Bio One Safety Lancets Product Portfolio
- 4.16.5 Greiner Bio One Recent Developments
- 4.17 Cardinal Health
- 4.17.1 Cardinal Health Company Information
- 4.17.2 Cardinal Health Business Overview
- 4.17.3 Cardinal Health Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Cardinal Health Safety Lancets Product Portfolio
- 4.17.5 Cardinal Health Recent Developments
- 4.18 BD
- 4.18.1 BD Company Information
- 4.18.2 BD Business Overview
- 4.18.3 BD Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 BD Safety Lancets Product Portfolio
- 4.18.5 BD Recent Developments
- 4.19 Ascensia
- 4.19.1 Ascensia Company Information
- 4.19.2 Ascensia Business Overview
- 4.19.3 Ascensia Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Ascensia Safety Lancets Product Portfolio
- 4.19.5 Ascensia Recent Developments
- 4.20 ARKRAY
- 4.20.1 ARKRAY Company Information
- 4.20.2 ARKRAY Business Overview
- 4.20.3 ARKRAY Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 ARKRAY Safety Lancets Product Portfolio
- 4.20.5 ARKRAY Recent Developments
5 Global Safety Lancets Market Scenario by Region
- 5.1 Global Safety Lancets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Safety Lancets Sales by Region: 2021-2032
- 5.2.1 Global Safety Lancets Sales by Region: 2021-2026
- 5.2.2 Global Safety Lancets Sales by Region: 2027-2032
- 5.3 Global Safety Lancets Revenue by Region: 2021-2032
- 5.3.1 Global Safety Lancets Revenue by Region: 2021-2026
- 5.3.2 Global Safety Lancets Revenue by Region: 2027-2032
- 5.4 North America Safety Lancets Market Facts & Figures by Country
- 5.4.1 North America Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Safety Lancets Sales by Country (2021-2032)
- 5.4.3 North America Safety Lancets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Safety Lancets Market Facts & Figures by Country
- 5.5.1 Europe Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Safety Lancets Sales by Country (2021-2032)
- 5.5.3 Europe Safety Lancets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Safety Lancets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Safety Lancets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Safety Lancets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Safety Lancets Market Facts & Figures by Country
- 5.7.1 South America Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Safety Lancets Sales by Country (2021-2032)
- 5.7.3 South America Safety Lancets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Safety Lancets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Safety Lancets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Safety Lancets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Safety Lancets Sales by Type (2021-2032)
- 6.1.1 Global Safety Lancets Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Safety Lancets Sales Market Share by Type (2021-2032)
- 6.2 Global Safety Lancets Revenue by Type (2021-2032)
- 6.2.1 Global Safety Lancets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Safety Lancets Revenue Market Share by Type (2021-2032)
- 6.3 Global Safety Lancets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Safety Lancets Sales by Application (2021-2032)
- 7.1.1 Global Safety Lancets Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Safety Lancets Sales Market Share by Application (2021-2032)
- 7.2 Global Safety Lancets Revenue by Application (2021-2032)
- 7.2.1 Global Safety Lancets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Safety Lancets Revenue Market Share by Application (2021-2032)
- 7.3 Global Safety Lancets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Safety Lancets Value Chain Analysis
- 8.1.1 Safety Lancets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Safety Lancets Production Mode & Process
- 8.2 Safety Lancets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Safety Lancets Distributors
- 8.2.3 Safety Lancets Customers
9 Global Safety Lancets Analyzing Market Dynamics
- 9.1 Safety Lancets Industry Trends
- 9.2 Safety Lancets Industry Drivers
- 9.3 Safety Lancets Industry Opportunities and Challenges
- 9.4 Safety Lancets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst